Stimulants and Prescription Diet Pills:

Also see Data tables on prescription type drugs

Also see All reports on prescription type drugs

The NSDUH Report:  Nonmedical Stimulant Use, Other Drug Use, Delinquent Behaviors, and Depression Among Adolescents

Misuse of prescription drugs  

The New DAWN Report:  Emergency Department Visits Involving ADHD Stimulant Medications

2006 NSDUH

   Results of the 2006 National Survey on Drug Use & Health (HTML format)

Chapter:  Illicit Drug Use

Detailed Tables

2005 NSDUH

   Results of the 2005 National Survey on Drug Use & Health (HTML format)

Chapter:  Illicit Drug Use

2004 NSDUH:

   Detailed Tables on NonMedical Use of Prescription type Drugs

 

Detailed Tables on NonMedical Use of Prescription type Drugs from 2003 NSDUH:

  2000 & 2001 National Household Survey on Drug Abuse:

The reports and tables below present data on persons reporting use of the following specific stimulants:  

Methedrine, Prescription Diet Pills, Ritalin®, Cylert®, Dexedrine®, Dextroamphetamine, Didrex®, Eskatrol®, Ionamin®, Mazanor®, Obedrin-LA®, Plegine®, Preludin®, and Sanorex®.

Other reports on prescription-type and over-the-counter (OTC) drugs

  

Click here to go to the top of this page.

Number (in Thousands) by Age Group and Survey Year (2000 & 2001)

Table 1.109A Estimated Numbers (in Thousands) of Lifetime Users of Specific Stimulants, by Age Group: 2000 and 2001

 

 

Stimulants

 

Total

AGE GROUP (Years)

12-17

18-25

26 or Older

2000

2001

2000

2001

2000

2001

2000

2001

Methamphetamine, Desoxyn®, or Methedrine

8,843

9,600

305

338

1,185b

1,510

7,353

7,752

Prescription Diet Pills1

6,605

7,004

282

241

548

630

5,776

6,134

Ritalin® or Methylphenidate

2,761b

3,442

506

472

1,055b

1,385

1,201

1,585

Cylert®

246

194

24

20

52

44

169

130

Dexedrine®

1,982

2,272

63

68

191b

281

1,729

1,923

Dextroamphetamine

634

494

28

38

77

75

528

381

Didrex®

182

165

16

15

20

25

145

125

Eskatrol®

152

83

11

10

22

3

118

70

Ionamin®

333

322

14

8

41

16

279

297

Mazanor®

93

77

23

16

19b

3

51

57

Obedrin-LA®

91

60

5

5

13

7

73

48

Plegine®

84

21

12

9

4

9

67

*

Preludin®

671

597

10

13

47

54

614

530

Sanorex®

106

98

18

19

26

32

63

46

Tenuate®

81

134

9

14

18

11

54

110

*Low precision; no estimate reported.

aDifference between estimate and 2001 estimate is statistically significant at the .05 level.

bDifference between estimate and 2001 estimate is statistically significant at the .01 level.

1 For example, Amphetamines, Benzedrine®, Biphetamine®, Fastin®, or Phentermine.

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 2000 and 2001.

  

Click here to go to the top of this page.

Percent by Age Group and Survey Year (2000 & 2001)

Table 1.109B Percentages Reporting Lifetime Use of Specific Stimulants, by Age Group: 2000 and 2001

 

 

Stimulants

 

Total

AGE GROUP (Years)

12-17

18-25

26 or Older

2000

2001

2000

2001

2000

2001

2000

2001

Methamphetamine, Desoxyn®, or Methedrine

4.0

4.3

1.3

1.4

4.1b

5.1

4.3

4.5

Prescription Diet Pills1

3.0

3.1

1.2

1.0

1.9

2.1

3.4

3.6

Ritalin® or Methylphenidate

1.2b

1.5

2.2

2.0

3.6b

4.7

0.7

0.9

Cylert®

0.1

0.1

0.1

0.1

0.2

0.1

0.1

0.1

Dexedrine®

0.9

1.0

0.3

0.3

0.7b

1.0

1.0

1.1

Dextroamphetamine

0.3

0.2

0.1

0.2

0.3

0.3

0.3

0.2

Didrex®

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Eskatrol®

0.1

0.0

0.0

0.0

0.1

0.0

0.1

0.0

Ionamin®

0.1

0.1

0.1

0.0

0.1

0.1

0.2

0.2

Mazanor®

0.0

0.0

0.1

0.1

0.1b

0.0

0.0

0.0

Obedrin-LA®

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Plegine®

0.0

0.0

0.1

0.0

0.0

0.0

0.0

*

Preludin®

0.3

0.3

0.0

0.1

0.2

0.2

0.4

0.3

Sanorex®

0.0

0.0

0.1

0.1

0.1

0.1

0.0

0.0

Tenuate®

0.0

0.1

0.0

0.1

0.1

0.0

0.0

0.1

*Low precision; no estimate reported.

aDifference between estimate and 2001 estimate is statistically significant at the .05 level.

bDifference between estimate and 2001 estimate is statistically significant at the .01 level.

1 For example, Amphetamines, Benzedrine®, Biphetamine®, Fastin®, or Phentermine.

Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 2000 and 2001.

This page was last updated on December 30, 2008.